Cancer risk in children, adolescents, and young adults conceived by ART in 1983-2011.

IF 8.3 Q1 OBSTETRICS & GYNECOLOGY
Human reproduction open Pub Date : 2023-06-01 eCollection Date: 2023-01-01 DOI:10.1093/hropen/hoad027
Mandy Spaan, Martina Pontesilli, Alexandra W van den Belt-Dusebout, Curt W Burger, Marry M van den Heuvel-Eibrink, Anita C J Ravelli, Mariëtte Goddijn, Cornelis B Lambalk, Tessa J Roseboom, Flora E van Leeuwen
{"title":"Cancer risk in children, adolescents, and young adults conceived by ART in 1983-2011.","authors":"Mandy Spaan, Martina Pontesilli, Alexandra W van den Belt-Dusebout, Curt W Burger, Marry M van den Heuvel-Eibrink, Anita C J Ravelli, Mariëtte Goddijn, Cornelis B Lambalk, Tessa J Roseboom, Flora E van Leeuwen","doi":"10.1093/hropen/hoad027","DOIUrl":null,"url":null,"abstract":"<p><strong>Study question: </strong>Do children, adolescents, and young adults born after ART, including IVF, ICSI and frozen-thawed embryo transfer (FET), have an increased risk of cancer compared with children born to subfertile couples not conceived by ART and children from the general population?</p><p><strong>Summary answer: </strong>After a median follow-up of 18 years, the overall cancer risk was not increased in children conceived by ART, but a slight risk increase was observed in children conceived after ICSI.</p><p><strong>What is known already: </strong>There is growing evidence that ART procedures could perturb epigenetic processes during the pre-implantation period and influence long-term health. Recent studies showed (non-)significantly increased cancer risks after ICSI and FET, but not after IVF.</p><p><strong>Study design size duration: </strong>A nationwide historical cohort study with prospective follow-up was carried out, including all live-born offspring from women treated with ART between 1983 and 2011 and subfertile women not treated with ART in one of the 13 Dutch IVF clinics and two fertility centers.</p><p><strong>Participants/materials setting methods: </strong>Children were identified through the mothers' records in the Personal Records Database. Information on the conception method of each child was collected through the mother's medical record. In total, the cohort comprises 89 249 live-born children of subfertile couples, of whom 51 417 were conceived using ART and 37 832 were not (i.e. conceived naturally, through ovulation induction, or after IUI). Cancer incidence was ascertained through linkage with the Netherlands Cancer Registry for the period 1989-2019. Cancer risk in children conceived using ART was compared with risk in children born to subfertile couples but not conceived by ART (hazard ratio (HR)) and children from the general population (standardized incidence ratios (SIRs)).</p><p><strong>Main results and the role of chance: </strong>In total, 358 cancers were observed after a median follow-up of 18 years. Overall cancer risk was not increased in children conceived using ART, when compared with the general population (SIR = 0.96, 95% CI = 0.81-1.12) or with children from subfertile couples not conceived by ART (HR = 1.06, 95% CI = 0.84-1.33). Compared with children from subfertile couples not conceived by ART, the use of IVF or FET was not associated with increased cancer risk, but ICSI was associated with a slight risk increase (HR = 1.58, 95% CI = 1.08-2.31). Risk of cancer after ART did not increase at older ages (≥18 years, HR = 1.26, 95% CI = 0.88-1.81) compared to cancer risk in children not conceived by ART.</p><p><strong>Limitations reasons for caution: </strong>The observed increased risk among children conceived using ICSI must be interpreted with caution owing to the small number of cases.</p><p><strong>Wider implications of the findings: </strong>After a median follow-up of 18 years, children conceived using ART do not have an increased overall cancer risk. Many large studies with prolonged follow-up are needed to investigate cancer risk in (young) adults conceived by different types of ART. In addition, international pooling of studies is recommended to provide sufficient power to study risk of specific cancer sites after ART.</p><p><strong>Study funding/competing interests: </strong>This work was supported by The Dutch Cancer Society (NKI 2006-3631) that funded the OMEGA-women's cohort, Children Cancer Free (KIKA; 147) that funded the OMEGA-I-II offspring cohort. The OMEGA-III offspring cohort was supported by a Postdoc Stipend of Amsterdam Reproduction & Development, and the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD088393. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no competing interests.</p><p><strong>Trial registration number: </strong>N/A.</p>","PeriodicalId":73264,"journal":{"name":"Human reproduction open","volume":null,"pages":null},"PeriodicalIF":8.3000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/36/hoad027.PMC10279651.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/hropen/hoad027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study question: Do children, adolescents, and young adults born after ART, including IVF, ICSI and frozen-thawed embryo transfer (FET), have an increased risk of cancer compared with children born to subfertile couples not conceived by ART and children from the general population?

Summary answer: After a median follow-up of 18 years, the overall cancer risk was not increased in children conceived by ART, but a slight risk increase was observed in children conceived after ICSI.

What is known already: There is growing evidence that ART procedures could perturb epigenetic processes during the pre-implantation period and influence long-term health. Recent studies showed (non-)significantly increased cancer risks after ICSI and FET, but not after IVF.

Study design size duration: A nationwide historical cohort study with prospective follow-up was carried out, including all live-born offspring from women treated with ART between 1983 and 2011 and subfertile women not treated with ART in one of the 13 Dutch IVF clinics and two fertility centers.

Participants/materials setting methods: Children were identified through the mothers' records in the Personal Records Database. Information on the conception method of each child was collected through the mother's medical record. In total, the cohort comprises 89 249 live-born children of subfertile couples, of whom 51 417 were conceived using ART and 37 832 were not (i.e. conceived naturally, through ovulation induction, or after IUI). Cancer incidence was ascertained through linkage with the Netherlands Cancer Registry for the period 1989-2019. Cancer risk in children conceived using ART was compared with risk in children born to subfertile couples but not conceived by ART (hazard ratio (HR)) and children from the general population (standardized incidence ratios (SIRs)).

Main results and the role of chance: In total, 358 cancers were observed after a median follow-up of 18 years. Overall cancer risk was not increased in children conceived using ART, when compared with the general population (SIR = 0.96, 95% CI = 0.81-1.12) or with children from subfertile couples not conceived by ART (HR = 1.06, 95% CI = 0.84-1.33). Compared with children from subfertile couples not conceived by ART, the use of IVF or FET was not associated with increased cancer risk, but ICSI was associated with a slight risk increase (HR = 1.58, 95% CI = 1.08-2.31). Risk of cancer after ART did not increase at older ages (≥18 years, HR = 1.26, 95% CI = 0.88-1.81) compared to cancer risk in children not conceived by ART.

Limitations reasons for caution: The observed increased risk among children conceived using ICSI must be interpreted with caution owing to the small number of cases.

Wider implications of the findings: After a median follow-up of 18 years, children conceived using ART do not have an increased overall cancer risk. Many large studies with prolonged follow-up are needed to investigate cancer risk in (young) adults conceived by different types of ART. In addition, international pooling of studies is recommended to provide sufficient power to study risk of specific cancer sites after ART.

Study funding/competing interests: This work was supported by The Dutch Cancer Society (NKI 2006-3631) that funded the OMEGA-women's cohort, Children Cancer Free (KIKA; 147) that funded the OMEGA-I-II offspring cohort. The OMEGA-III offspring cohort was supported by a Postdoc Stipend of Amsterdam Reproduction & Development, and the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD088393. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no competing interests.

Trial registration number: N/A.

Abstract Image

Abstract Image

1983-2011年通过抗逆转录病毒疗法受孕的儿童、青少年和年轻成人的癌症风险。
研究问题与非通过 ART 受孕的亚育夫妇所生子女和普通人群所生子女相比,通过 ART(包括体外受精、卵胞浆内单精子显微注射和冻融胚胎移植)受孕的儿童、青少年和年轻人患癌症的风险是否会增加?在中位随访 18 年后,通过 ART 受孕的儿童患癌症的总体风险没有增加,但在 ICSI 受孕的儿童中观察到风险略有增加:越来越多的证据表明,抗逆转录病毒疗法可能会扰乱胚胎植入前的表观遗传过程,并影响长期健康。最近的研究显示,ICSI 和 FET(非)明显增加了癌症风险,但 IVF(试管婴儿)则没有:进行了一项全国范围的前瞻性追踪历史队列研究,研究对象包括1983年至2011年间在荷兰13家试管婴儿诊所和两家生殖中心之一接受ART治疗的女性和未接受ART治疗的亚健康女性的所有活产后代:通过个人记录数据库(Personal Records Database)中母亲的记录确定子女的身份。每个孩子的受孕方式信息通过母亲的医疗记录收集。队列中共有 89 249 名亚不育夫妇的活产子女,其中 51 417 名是通过抗逆转录病毒疗法受孕的,37 832 名不是(即通过自然受孕、促排卵或人工授精后受孕)。癌症发病率是通过与荷兰癌症登记处(Netherlands Cancer Registry)在 1989-2019 年期间的联系确定的。采用抗逆转录病毒疗法受孕的儿童患癌症的风险与亚健康夫妇所生但未采用抗逆转录病毒疗法受孕的儿童患癌症的风险(危险比(HR))和普通人群儿童患癌症的风险(标准化发病率比(SIR))进行了比较:中位随访 18 年后,共观察到 358 例癌症。与普通人群相比(SIR = 0.96,95% CI = 0.81-1.12),或与非抗逆转录病毒疗法受孕的亚育夫妇的子女相比(HR = 1.06,95% CI = 0.84-1.33),抗逆转录病毒疗法受孕的子女患癌症的总体风险并没有增加。与未通过 ART 受孕的亚育夫妇的子女相比,使用 IVF 或 FET 与癌症风险增加无关,但 ICSI 与风险轻微增加有关(HR = 1.58,95% CI = 1.08-2.31)。与未通过人工授精受孕的儿童相比,年龄较大(≥18 岁,HR = 1.26,95% CI = 0.88-1.81)的儿童在人工授精后患癌症的风险并没有增加:由于病例数量较少,因此必须谨慎解释在采用卵胞浆内单精子显微注射法受孕的儿童中观察到的风险增加:中位随访 18 年后,采用 ART 技术受孕的儿童患癌症的总体风险并没有增加。要调查通过不同类型的抗逆转录病毒疗法受孕的(年轻)成年人患癌症的风险,还需要许多大型研究和长期随访。此外,建议在国际范围内开展联合研究,以提供足够的力量来研究抗逆转录病毒疗法后特定癌症部位的风险:这项工作得到了荷兰癌症协会(NKI 2006-3631)的支持,该协会资助了OMEGA-女性队列,儿童癌症免费协会(KIKA; 147)资助了OMEGA-I-II后代队列。OMEGA-III后代队列得到了阿姆斯特丹生殖与发育研究所博士后奖学金和美国国立卫生研究院尤妮斯-肯尼迪-施莱佛国家儿童健康与人类发展研究所(Eunice Kennedy Shriver National Institute of Child Health & Human Development)的资助,奖金编号为R01HD088393。内容仅代表作者本人,不代表美国国立卫生研究院的官方观点。作者声明不存在利益冲突。试验注册号:N/A:不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.50
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信